Top

A--Notice of the Government's Intent to Award A Sole Source Contract in accordance with FAR 6.302-1 for the requirement entitled Adenovirus Vaccine Expiration Dating Period (Shelf Life) Extension.

Active

W81XWH15R0036Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

The government intends to award a sole source, cost-plus-fixed-fee contract to Barr Laboratories Inc./Teva Women's Health for the extension of the expiration dating period (shelf life) of the Adenovirus Vaccine. This action is authorized under 10 U.S.C. 2304(c)(1) and FAR 6.302-1, which allow for non-competitive procurement when only one responsible source is available to meet the agency's specific requirements. The North American Industry Classification System code governing this contract is 541711. Barr Laboratories/Teva Women's Health, which is not classified as a small business, is deemed the only supplier capable of providing the necessary services, and the government plans to finalize the award within 90 days from the notice. Although this notice is not a request for competitive proposals, other firms that believe they can fulfill the requirement fully may submit capability statements within seven days of this publication. These statements must be limited to five pages and emailed to the designated contact for evaluation to determine if a competitive process is warranted. Ultimately, the decision to proceed with or forego competition rests with the government. This notice serves as the only formal announcement of intent to negotiate and award this sole source contract, underlining the unique and essential nature of Barr Laboratories/Teva Women's Health’s capabilities in this matter.

General Info

Sole source, cost-plus-fixed-fee contract to Teva for Adenovirus Vaccine shelf life extension.

Agency

N/A

NAICS

541711 - Research and Development in Biotechnology

Place of Performance

Not specified

Set-Aside

NONE

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedApr 6

special-notice

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyN/A

ContactsNo contacts available

OfficeN/A

Organization / Agency

N/A

Office AddressN/A

ContactsNo contact information available

Full Description

This notice is published in accordance with Federal Acquisition Regulation (FAR) Part 5.101(a)(1) requiring the dissemination of information regarding proposed contract actions. This is a Notice of Intent to award a Sole Source, Cost Plus Fixed Fee Contract under the authority of 10 U.S.C. 2304(c)(1), as implemented by FAR 6.302-1, Only One Responsible Source and No Other Supplies or Service Will Satisfy Agency Requirements, and is not a request for competitive proposals. USAMRAA, MRMC-AAA-SD, 820 Chandler Street, Fort Detrick, MD 21702-5014 intends to award a cost plus fixed fee, sole source contract to Barr Laboratories Inc./Teva Women's Health, for Adenovirus Vaccine Expiration Dating Period (Shelf Life) Extension. The North American Industry Classification (NAICS) code for this acquisition is 541711. Barr Laboratories/Teva Women's Health is not a small business. This will be the only notice of the Government's intent to solicit, negotiate, and award to one source to satisfy this requirement. The Government plans to award a contract for this requirement within 90 days of this notice. While this synopsis does not constitute a solicitation, interested vendors may identify their interest and capability to satisfy this requirement. The Government understands that Barr Laboratories/Teva Women's Health is the only vendor that can provide the services required for the potential extension of Adenovirus Vaccine Expiration Dating Period (Shelf Life). However, firms that believe they can provide the capability required to fully meet the Government's requirement may submit a capabilities statement in writing to the identified point of contact within seven (7) calendar days after publication of this notice. Capability statements shall not exceed five (5) pages and must be submitted by e-mail to Shannyn Scassero at contact@example.gov. Such documentation shall be evaluated solely for the purpose of determining whether or not to conduct this procurement on a competitive basis. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

Similar Contracts

Same NAICS industry code